1-3 of 3
Emily K. Slotkin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA

Peter Anderson, Maurizio Ghisoli, Brian D. Crompton, Kelly S. Klega, Leonard H. Wexler, Emily K. Slotkin, Laura Stanbery, Luisa Manning, Gladice Wallraven, Meghan Manley, Staci Horvath, Ernest Bognar, John Nemunaitis
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1689–1697.
https://doi.org/10.1158/1078-0432.CCR-22-2292
Published: 01 May 2023
View article titled, Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA
Open the PDF for Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA in another window
Includes: Supplementary data
Journal Articles

HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome

Evan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, Mark Dickson, Mrinal Gounder, Mary L. Keohan, Ping Chi, Ciara Kelly, Sujana Movva, Benjamin Nacev, Noemi Simeone, Mark Donoghue, Emily K. Slotkin, Li-Xuan Qin, Cristina R. Antonescu, William D. Tap, Sandra P. D'Angelo
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5448–5455.
https://doi.org/10.1158/1078-0432.CCR-20-0832
Published: 15 October 2020
View article titled, HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome
Open the PDF for HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome in another window
Includes: Supplementary data
Journal Articles

Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma

Dana L. Casey, Leonard H. Wexler, Kenneth L. Pitter, Robert M. Samstein, Emily K. Slotkin, Suzanne L. Wolden
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 1135–1140.
https://doi.org/10.1158/1078-0432.CCR-19-2631
Published: 02 March 2020
View article titled, Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma
Open the PDF for Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma in another window
Includes: Supplementary data